Taal BG - Search Results

1

Renal excretion of meta-iodobenzylguanidine after therapeutic doses in cancer patients and its relation to dose and creatinine clearance.

Wafelman AR, Nortier YL, Rosing H, Maessen HJ, Taal BG, Hoefnagel CA, Maes RA, Beijnen JH. Wafelman AR, et al. Among authors: taal bg. Nucl Med Commun. 1995 Sep;16(9):767-72. doi: 10.1097/00006231-199509000-00007. Nucl Med Commun. 1995. PMID: 7478409

2

Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine.

Hoefnagel CA, Den Hartog Jager FC, Van Gennip AH, Marcuse HR, Taal BG. Hoefnagel CA, et al. Among authors: taal bg. Clin Nucl Med. 1986 Mar;11(3):150-2. doi: 10.1097/00003072-198603000-00002. Clin Nucl Med. 1986. PMID: 3956021

3

High-performance liquid chromatographic determination of metaiodobenzylguanidine in whole blood and plasma of cancer patients.

Wafelman AR, Konings MC, Rosing H, Hoefnagel CA, Taal BG, Maes RA, Beijnen JH. Wafelman AR, et al. Among authors: taal bg. J Pharm Biomed Anal. 1994 Sep;12(9):1173-9. doi: 10.1016/0731-7085(94)e0034-x. J Pharm Biomed Anal. 1994. PMID: 7803569

4

Palliative effect of metaiodobenzylguanidine in metastatic carcinoid tumors.

Taal BG, Hoefnagel CA, Valdes Olmos RA, Boot H, Beijnen JH. Taal BG, et al. J Clin Oncol. 1996 Jun;14(6):1829-38. doi: 10.1200/JCO.1996.14.6.1829. J Clin Oncol. 1996. PMID: 8656251

5

Enhancement of 131I-MIBG uptake in carcinoid tumours by administration of unlabelled MIBG.

Hoefnagel CA, Taal BG, Sivro F, Boot H, Valdes Olmos RA. Hoefnagel CA, et al. Among authors: taal bg. Nucl Med Commun. 2000 Aug;21(8):755-61. doi: 10.1097/00006231-200008000-00009. Nucl Med Commun. 2000. PMID: 11039459 Clinical Trial.

6

Role of [131I]metaiodobenzylguanidine therapy in carcinoids.

Hoefnagel CA, Taal BG, Valdés Olmos RA. Hoefnagel CA, et al. Among authors: taal bg. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):346-8. J Nucl Biol Med (1991). 1991. PMID: 1726678

7

Effect of loperamide and delay of bowel motility on bile acid malabsorption caused by late radiation damage and ileal resection.

Valdés Olmos R, den Hartog Jager F, Hoefnagel C, Taal B. Valdés Olmos R, et al. Eur J Nucl Med. 1991;18(5):346-50. doi: 10.1007/BF02285463. Eur J Nucl Med. 1991. PMID: 1936043

8

Imaging and retention measurements of selenium 75 homocholic acid conjugated with taurine, and the carbon 14 glycochol breath test to document ileal dysfunction due to late radiation damage.

Olmos RV, den Hartog Jager F, Hoefnagel C, Taal B. Olmos RV, et al. Eur J Nucl Med. 1991;18(2):124-8. doi: 10.1007/BF00950758. Eur J Nucl Med. 1991. PMID: 2044571

9

[Therapeutic advances of nuclear medicine in oncology].

Valdés Olmos RA, Hoefnagel CA, Bais E, Boot H, Taal B, de Kraker J, Vote PA. Valdés Olmos RA, et al. Rev Esp Med Nucl. 2001 Dec;20(7):547-57. doi: 10.1016/s0212-6982(01)72011-3. Rev Esp Med Nucl. 2001. PMID: 11709141 Review. Spanish.

10

Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.

Taal BG, Hoefnagel CA, Valdés Olmos RA, Boot H. Taal BG, et al. Eur J Cancer. 1996 Oct;32A(11):1924-32. doi: 10.1016/0959-8049(96)00241-9. Eur J Cancer. 1996. PMID: 8943676 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters